Page last updated: 2024-08-24

pemirolast and carboplatin

pemirolast has been researched along with carboplatin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirakawa, T; Itoh, Y; Nakano, H; Oishi, R; Saito, M; Sendo, T; Uchida, M; Yahata, H	1
Egashira, N; Kawashiri, T; Oishi, R; Yano, T	1

Trials

1 trial(s) available for pemirolast and carboplatin

Article	Year
Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer. International journal of cancer, 2006, May-15, Volume: 118, Issue:10 Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Ovarian Neoplasms; Paclitaxel; Placebos; Pyridines; Pyrimidinones	2006

Article

Year

Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer.

International journal of cancer, 2006, May-15, Volume: 118, Issue:10

Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Ovarian Neoplasms; Paclitaxel; Placebos; Pyridines; Pyrimidinones

2006

Other Studies

1 other study(ies) available for pemirolast and carboplatin

Article	Year
[Substance P in antitumor drug-induced adverse reactions]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2013, Volume: 142, Issue:5 Topics: Animals; Antineoplastic Agents; Carboplatin; Histamine Antagonists; Humans; Nausea; Neuropeptides; Paclitaxel; Pyridines; Pyrimidinones; Substance P; Vomiting	2013